The hypothalamic-pituitary-gonadal (HPG) axis is one of the most closely studied hormone systems in biology. Three research compounds act at different levels of it: gonadorelin, a synthetic version of hypothalamic gonadotropin-releasing hormone (GnRH); human chorionic gonadotropin (HCG), which activates the LH receptor; and human menopausal gonadotropin (HMG), a preparation with both FSH and LH activity. Knowing where each one acts is the key to choosing between them in an experiment. This guide explains the axis, the receptor biology and the main design considerations.
These compounds are supplied by BioSim for laboratory research only. They are not for human or veterinary use, and nothing here is guidance on administration to people or animals.
The HPG Axis in Brief
The axis has three levels:
- Hypothalamus. Neurons release GnRH in pulses into the portal blood supply of the pituitary.
- Anterior pituitary. Gonadotroph cells respond to GnRH by making and releasing luteinizing hormone (LH) and follicle-stimulating hormone (FSH). LH and FSH share a common α subunit and differ in their β subunits.
- Gonads. LH and FSH act on the ovary and testis to drive steroid production and gamete development. Gonadal steroids feed back on the hypothalamus and pituitary.
A research compound can enter this system at the top (GnRH), or bypass the upper levels and act directly at the gonadal receptors (HCG and HMG).
Gonadorelin (GnRH): Acting at the Pituitary
GnRH is a decapeptide whose sequence was first proposed from porcine hypothalamic extracts in 1971 (Matsuo et al., 1971): pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2. Gonadorelin is the synthetic peptide with this native sequence. It acts on the GnRH receptor, a G protein-coupled receptor on pituitary gonadotrophs.
The most important feature of GnRH biology for experimental design is that the pattern of delivery matters as much as the amount:
- Pulsatile vs continuous. In rhesus monkeys with hypothalamic lesions that abolished gonadotropin release, constant infusion of GnRH failed to restore sustained gonadotropin secretion, while intermittent delivery once per hour restored it. Starting continuous GnRH in animals whose secretion had been restored by pulses caused desensitization (Belchetz et al., 1978).
- Pulse frequency selects the output. In rats, fast GnRH pulses (every 8 minutes) increased α-subunit and LHβ mRNA but not FSHβ mRNA. Pulses every 30 minutes increased all three. Slow pulses (every 120 to 480 minutes) increased FSHβ mRNA without changing α or LHβ. Experiments that equalized the total GnRH given over 24 hours confirmed that frequency, not total amount, drove these differences (Dalkin et al., 1989).
- Transcription rates. Further rat studies found that continuous GnRH infusion did not increase transcription of any of the three subunit genes, whereas pulses every 8 or 30 minutes increased α-subunit transcription (Haisenleder et al., 1991).
This makes gonadorelin a precise tool for studying pituitary function, but only if the delivery pattern is controlled and reported.
HCG: Acting at the LH/CG Receptor
HCG is a glycoprotein hormone made by the placenta. It shares the common α subunit with LH, FSH and TSH, and its β subunit is closely related to LHβ. HCG and LH both bind the same receptor, the lutropin/choriogonadotropin receptor (LHCGR). This receptor is essential for ovulation, for normal Leydig cell development in males, and for sustaining progesterone production in early pregnancy (Ascoli et al., 2002).
HCG and LH are not interchangeable. A review of their differences notes that, although they share a receptor, they have different effects on downstream signaling (Choi & Smitz, 2014). Direct comparisons support this:
- In cells expressing LHCGR, HCG was about 5-fold more potent than LH at stimulating cAMP, while LH reached its maximal effect faster.
- In primary human granulosa cells, cAMP production was higher with HCG, while ERK1/2 and AKT activation was stronger and more sustained with LH.
- Some target genes responded differently to the two ligands, depending on the pathway involved (Casarini et al., 2012).
HCG is commonly used in research as a long-acting LHCGR agonist, for example in Leydig cell steroidogenesis studies and ovarian models.
HMG: FSH and LH Activity Together
HMG (menotropins) is a gonadotropin preparation purified from urine of postmenopausal women. It contains both FSH and LH activity. FSH acts through the FSH receptor (FSHR), a G protein-coupled receptor expressed mainly on granulosa cells in the ovary and Sertoli cells in the testis (Simoni et al., 1997). The LH activity in HMG acts through LHCGR.
HMG is used when a study needs combined FSH and LH receptor stimulation, for example in models of follicle development or spermatogenesis. Because it is a biological extract, its activity is expressed in international units (IU), and the ratio of FSH to LH activity is defined by the preparation.
Side-by-Side Comparison
| Property | Gonadorelin (GnRH) | HCG | HMG |
|---|---|---|---|
| Type | Synthetic decapeptide | Placental glycoprotein hormone | Urinary gonadotropin preparation |
| Level of action | Pituitary | Gonads | Gonads |
| Receptor | GnRH receptor | LHCGR | FSHR and LHCGR |
| Requires functioning pituitary | Yes | No | No |
| Key design factor | Pulse frequency and pattern | Ligand-specific signaling vs LH | FSH-to-LH activity ratio |
| Key reference | Belchetz et al., 1978 | Casarini et al., 2012 | Simoni et al., 1997 |
Experimental Design Notes
- Choose the level of the axis. Use gonadorelin to study pituitary responses and feedback. Use HCG or HMG to study gonadal responses directly, independent of the pituitary.
- Control the delivery pattern for GnRH. Report pulse interval and duration, and remember that continuous exposure can desensitize the pituitary (Belchetz et al., 1978; Dalkin et al., 1989).
- Do not assume HCG is identical to LH. The two ligands differ in signaling kinetics and pathway bias at the same receptor (Casarini et al., 2012).
- Measure the right endpoints. Subunit mRNA, LH and FSH secretion, steroid output (testosterone, estradiol, progesterone) and cAMP or ERK signaling each capture a different level of the axis.
- Account for feedback. Gonadal steroids act back on the hypothalamus and pituitary, so intact animal models behave differently from isolated cell systems.
For related reading, see our overview of peptide receptor signaling, the Melanotan 2 vs PT-141 comparison and our Reproductive and Melanocortin Research category.
Handling in the Lab
All three are supplied lyophilized. HCG and HMG are glycoproteins and are more sensitive to agitation and heat than small peptides, so reconstitute gently, avoid foaming, aliquot and avoid repeated freeze-thaw cycles. Follow the storage conditions on the label and see our storage and stability guide.
Frequently Asked Questions
What is the difference between GnRH and gonadorelin?
GnRH is the natural hypothalamic hormone. Gonadorelin is the synthetic peptide with the same native decapeptide sequence (Matsuo et al., 1971).
Can HCG be used as a substitute for LH in experiments?
Both act on LHCGR, but they differ in potency and downstream signaling, so results with HCG should not be assumed to match LH (Casarini et al., 2012; Choi & Smitz, 2014).
Why does GnRH pulse frequency matter?
Different pulse frequencies favor LH or FSH subunit expression, and continuous exposure causes desensitization (Dalkin et al., 1989; Belchetz et al., 1978).
How do I confirm the identity of my lot?
Every BioSim lot is third-party tested, with identity confirmed by mass spectrometry. Available certificates are published on our COA page.
References
- Ascoli M, Fanelli F, Segaloff DL (2002). The lutropin/choriogonadotropin receptor, a 2002 perspective. Endocrine reviews, 23(2), 141-74. PMID: 11943741 · DOI: 10.1210/edrv.23.2.0462
- Belchetz PE, Plant TM, Nakai Y, et al. (1978). Hypophysial responses to continuous and intermittent delivery of hypopthalamic gonadotropin-releasing hormone. Science (New York, N.Y.), 202(4368), 631-3. PMID: 100883 · DOI: 10.1126/science.100883
- Casarini L, Lispi M, Longobardi S, et al. (2012). LH and hCG action on the same receptor results in quantitatively and qualitatively different intracellular signalling. PloS one, 7(10), e46682. PMID: 23071612 · DOI: 10.1371/journal.pone.0046682
- Choi J, Smitz J (2014). Luteinizing hormone and human chorionic gonadotropin: origins of difference. Molecular and cellular endocrinology, 383(1-2), 203-13. PMID: 24365330 · DOI: 10.1016/j.mce.2013.12.009
- Dalkin AC, Haisenleder DJ, Ortolano GA, et al. (1989). The frequency of gonadotropin-releasing-hormone stimulation differentially regulates gonadotropin subunit messenger ribonucleic acid expression. Endocrinology, 125(2), 917-24. PMID: 2502379 · DOI: 10.1210/endo-125-2-917
- Haisenleder DJ, Dalkin AC, Ortolano GA, et al. (1991). A pulsatile gonadotropin-releasing hormone stimulus is required to increase transcription of the gonadotropin subunit genes: evidence for differential regulation of transcription by pulse frequency in vivo. Endocrinology, 128(1), 509-17. PMID: 1702704 · DOI: 10.1210/endo-128-1-509
- Matsuo H, Baba Y, Nair RM, et al. (1971). Structure of the porcine LH- and FSH-releasing hormone. I. The proposed amino acid sequence. Biochemical and biophysical research communications, 43(6), 1334-9. PMID: 4936338 · DOI: 10.1016/s0006-291x(71)80019-0
- Simoni M, Gromoll J, Nieschlag E (1997). The follicle-stimulating hormone receptor: biochemistry, molecular biology, physiology, and pathophysiology. Endocrine reviews, 18(6), 739-73. PMID: 9408742 · DOI: 10.1210/edrv.18.6.0320
Research These Compounds: HCG 6000IU, HMG 75IU and GnRH 2mg from BioSim Peptides: 99%+ purity, every lot third-party tested with identity confirmed by mass spectrometry, and available certificates published on our COA page. For laboratory research use only. Not for human consumption.
